Literature DB >> 28471271

Extracellular Matrix Hydrogel Derived from Human Umbilical Cord as a Scaffold for Neural Tissue Repair and Its Comparison with Extracellular Matrix from Porcine Tissues.

Zuzana Kočí1,2, Karel Výborný1,2, Jana Dubišová1,2, Irena Vacková1, Aleš Jäger3, Oleg Lunov3, Klára Jiráková1, Šárka Kubinová1.   

Abstract

Extracellular matrix (ECM) hydrogels prepared by tissue decellularization have been reported as natural injectable materials suitable for neural tissue repair. In this study, we prepared ECM hydrogel derived from human umbilical cord (UC) and evaluated its composition and mechanical and biological properties in comparison with the previously described ECM hydrogels derived from porcine urinary bladder (UB), brain, and spinal cord. The ECM hydrogels did not differ from each other in the concentration of collagen, while the highest content of glycosaminoglycans as well as the shortest gelation time was found for UC-ECM. The elastic modulus was then found to be the highest for UB-ECM. In spite of a different origin, topography, and composition, all ECM hydrogels similarly promoted the migration of human mesenchymal stem cells (MSCs) and differentiation of neural stem cells, as well as axonal outgrowth in vitro. However, only UC-ECM significantly improved proliferation of tissue-specific UC-derived MSCs when compared with the other ECMs. Injection of UC-ECM hydrogels into a photothrombotic cortical ischemic lesion in rats proved its in vivo gelation and infiltration with host macrophages. In summary, this study proposes UC-ECM hydrogel as an easily accessible biomaterial of human origin, which has the potential for neural as well as other soft tissue reconstruction.

Entities:  

Keywords:  extracellular matrix; hydrogel; mesenchymal stromal cells; neural tissue; regeneration; umbilical cord

Mesh:

Substances:

Year:  2017        PMID: 28471271     DOI: 10.1089/ten.TEC.2017.0089

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  21 in total

Review 1.  The influence of microenvironment and extracellular matrix molecules in driving neural stem cell fate within biomaterials.

Authors:  Thomas Wilems; Sangamithra Vardhan; Siliang Wu; Shelly Sakiyama-Elbert
Journal:  Brain Res Bull       Date:  2019-03-18       Impact factor: 4.077

Review 2.  Extracellular matrix hydrogel therapies: In vivo applications and development.

Authors:  Martin T Spang; Karen L Christman
Journal:  Acta Biomater       Date:  2017-12-20       Impact factor: 8.947

3.   Extracellular Matrix-Based Biomaterials and Their Influence Upon Cell Behavior.

Authors:  Madeline C Cramer; Stephen F Badylak
Journal:  Ann Biomed Eng       Date:  2019-11-18       Impact factor: 3.934

4.  Porcine Lung-Derived Extracellular Matrix Hydrogel Properties Are Dependent on Pepsin Digestion Time.

Authors:  Robert A Pouliot; Bethany M Young; Patrick A Link; Heon E Park; Alison R Kahn; Keerthana Shankar; Matthew B Schneck; Daniel J Weiss; Rebecca L Heise
Journal:  Tissue Eng Part C Methods       Date:  2020-06-09       Impact factor: 3.056

5.  Decellularized Human Umbilical Tissue-Derived Hydrogels Promote Proliferation and Chondrogenic Differentiation of Mesenchymal Stem Cells.

Authors:  Faiza Ramzan; Sobia Ekram; Trivia Frazier; Asmat Salim; Omair Anwar Mohiuddin; Irfan Khan
Journal:  Bioengineering (Basel)       Date:  2022-05-30

Review 6.  A roadmap for promoting endogenous in situ tissue restoration using inductive bioscaffolds after acute brain injury.

Authors:  Michel Modo; Stephen F Badylak
Journal:  Brain Res Bull       Date:  2019-05-22       Impact factor: 3.715

7.  Biodegradation of ECM hydrogel promotes endogenous brain tissue restoration in a rat model of stroke.

Authors:  Harmanvir Ghuman; Carrinton Mauney; Julia Donnelly; Andre R Massensini; Stephen F Badylak; Michel Modo
Journal:  Acta Biomater       Date:  2018-09-16       Impact factor: 10.633

8.  Extracellular matrix based biomaterials for central nervous system tissue repair: the benefits and drawbacks.

Authors:  Sarka Kubinova
Journal:  Neural Regen Res       Date:  2017-09       Impact factor: 5.135

Review 9.  Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis.

Authors:  Eva Sykova; Dasa Cizkova; Sarka Kubinova
Journal:  Front Cell Dev Biol       Date:  2021-07-06

10.  The Effect of Human Mesenchymal Stem Cells Derived from Wharton's Jelly in Spinal Cord Injury Treatment Is Dose-Dependent and Can Be Facilitated by Repeated Application.

Authors:  Petr Krupa; Irena Vackova; Jiri Ruzicka; Kristyna Zaviskova; Jana Dubisova; Zuzana Koci; Karolina Turnovcova; Lucia Machova Urdzikova; Sarka Kubinova; Svatopluk Rehak; Pavla Jendelova
Journal:  Int J Mol Sci       Date:  2018-05-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.